Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomonori Habuchi

Showing results (1-10 of 460) with videos related to

Pageof 46
Sort By:
International Journal of Clinical Oncology|June 1, 2011
Role of lymph node dissection in managing urologic cancersTomonori Habuchi
International Journal of Urology : Official Journal of the Japanese Urological Association|September 22, 2005
Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implicationsTomonori Habuchi
Future Oncology (London, England)|March 28, 2006
Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a modelTomonori Habuchi
European Urology|March 4, 2023
Re: Continuous Enzalutamide After Progression of Metastatic Castration-resistant Prostate Cancer Treated with Docetaxel (PRESIDE): An International, Randomised, Phase 3b StudyTomonori Habuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[Genetic polymorphisms in prostate cancer]Norihiko Tsuchiya, Tomonori Habuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 18, 2005
[Mechanism of prostate cancer development]Norihiko Tsuchiya, Tomonori Habuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 23, 2016
[Current status of castration-resistant prostate cancer translational research]Atsushi Maeno, Tomonori Habuchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 9, 2005
[Tumor markers in prostate cancer--clinical significance and future prospect of prostate specific antigen (PSA)]Norihiko Tsuchiya, Chikara Ohyama, Tomonori Habuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 28, 2016
[Recent trend in the development of novel treatments based on the mechanisms of prostate cancer progression]Takamitsu Inoue, Shintaro Narita, Tomonori Habuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 26, 2003
[Molecular and endocrinological mechanism of benign prostatic hyperplasia and prostate cancer]Hidefumi Kinoshita, Tomonori Habuchi, Osamu Ogawa
Pageof 46

Showing results (1-10 of 460) with videos related to

Sort By:
Pageof 46
International Journal of Clinical Oncology|June 1, 2011
Role of lymph node dissection in managing urologic cancersTomonori Habuchi
International Journal of Urology : Official Journal of the Japanese Urological Association|September 22, 2005
Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implicationsTomonori Habuchi
Future Oncology (London, England)|March 28, 2006
Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a modelTomonori Habuchi
European Urology|March 4, 2023
Re: Continuous Enzalutamide After Progression of Metastatic Castration-resistant Prostate Cancer Treated with Docetaxel (PRESIDE): An International, Randomised, Phase 3b StudyTomonori Habuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[Genetic polymorphisms in prostate cancer]Norihiko Tsuchiya, Tomonori Habuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 18, 2005
[Mechanism of prostate cancer development]Norihiko Tsuchiya, Tomonori Habuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 23, 2016
[Current status of castration-resistant prostate cancer translational research]Atsushi Maeno, Tomonori Habuchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 9, 2005
[Tumor markers in prostate cancer--clinical significance and future prospect of prostate specific antigen (PSA)]Norihiko Tsuchiya, Chikara Ohyama, Tomonori Habuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 28, 2016
[Recent trend in the development of novel treatments based on the mechanisms of prostate cancer progression]Takamitsu Inoue, Shintaro Narita, Tomonori Habuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 26, 2003
[Molecular and endocrinological mechanism of benign prostatic hyperplasia and prostate cancer]Hidefumi Kinoshita, Tomonori Habuchi, Osamu Ogawa
Pageof 46